Skip to main content
OpenTrials
Completed

NCT Number: NCT03171350

Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Patients With Acute Pharyngitis.

Participants who meet the eligibility criteria and who consent to participation or whose parents/legal guardian consent to their participation, will be enrolled in the study for a period of up to 14 days. Enrolment visit (Day 1) assessments for all participants will include the collection of throat swabs, testing by staff at the site using the ellume·lab Group A Strep Test and testing for Group A Streptococcus by a central laboratory using bacterial culture and polymerase chain reaction (PCR). All participants will be followed up with a phone assessment of adverse events between Days 2-14.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ochre Health Medical Centre, Casey, Australian Capital Territory, Australia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female participants aged 3 years of age or older
  • Must currently be presenting with symptoms characteristic of pharyngitis, possibly Group A Strep, including:
  • Acute onset of sore throat;
  • Fever ≥ 37.8° C (100° F) at presentation or history or parent/guardian-reported history of fever ≥ 37.8° C or feeling feverish within 24 hours of presentation and;
  • At least one of the following:
  • Red and swollen/inflamed tonsils;
  • Pharyngeal or tonsillar exudate; o Cervical lymphadenopathy
  • ≤ 5 days from onset of signs and symptoms of pharyngitis
  • Parent/legal guardian of Participants < 18 years of age capable and willing to give informed consent
  • Participants ≥18 years of age capable and willing to give informed consent

Exclusion criteria

  • Participants < 3 years of age
  • Participants undergoing treatment with antibiotics, or those who have undergone treatment with antibiotics for current episode of pharyngitis
  • Participants who have pharyngitis with clinical features that suggest a viral etiology such as, cough, runny nose, upper respiratory symptoms, and/or oral ulcers
  • Currently enrolled in another clinical trial or used any investigational device within 30 days preceding informed consent
  • Participants 18 years of age or older unable to understand English and consent to participation
  • Parent/legal guardian of Participants < 18 years of age unable to understand English and consent to participation of child

Treatment and study plan

ellume.lab Group A Streptococcus Test

Diagnostic Test

ellume.lab Group A Streptococcus Test is a rapid diagnostic test intended to be used as an aid in the diagnosis of Group A Streptococcus in symptomatic patients. The sample type used is a throat swab.

Primary outcomes

  1. The sensitivity of the ellume·lab Group A Strep Test in detecting Group A Streptococcus in samples collected using a throat swab as compared to bacterial culture

    Time frame: 1 week

  2. The specificity of the ellume·lab Group A Strep Test in detecting Group A Streptococcus in samples collected using a throat swab as compared to bacterial culture

    Time frame: 1 week

  3. The overall agreement between the ellume·lab Group A Strep Test in detecting Group A Streptococcus in samples collected using a throat swab and results from bacterial culture

    Time frame: 1 week

Secondary outcomes

  1. The sensitivity of the ellume·lab Group A Strep Test in detecting Group A Streptococcus in samples collected using a throat swab as compared to PCR

    Time frame: 1 week

  2. The specificity of the ellume·lab Group A Strep Test in detecting Group A Streptococcus in samples collected using throat swab as compared to PCR

    Time frame: 1 week

  3. The overall agreement between the ellume·lab Group A Strep Test in detecting Group A Streptococcus in samples collected using a throat swab and results from PCR

    Time frame: 1 week

  4. Ease of use as assessed by operator questionnaire.

    Time frame: 1 week

Sponsors and collaborators

Lead sponsor

Ellume Pty Ltd

Industry

Registry information

Official study title

A Prospective Multi-Centre Study of the Performance of the Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
May 31, 2017
Registry last updated
Sep 24, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.